萬達生物製藥 VNDA 深 滬
等待開盤 07-06 09:30:00 美东时间
6.21
+0.160
+2.64%
華盛通- 最 高6.23
- 今 開6.06
- 成交量 85.91万股
- 最 低 6.01
- 昨 收 6.05
- 總市值 3.73亿
- 52周最高 9.94
- 市盈率 靜 --
- 換手率 1.43%
- 52周最低 4.14
- 委 比 -30.35%
- 總股本 6013.56万
- 歷史最高 33.44
- 量 比 0.98
- 振 幅 3.64%
- 歷史最低 2.92
- 每 手 1
- 風險率 1.33%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Vanda Pharmaceuticals Receives Japanese Orphan Drug Designation For Imsidolimab In Generalized Pustular Psoriasis
Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA) today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has granted orphan drug designation to imsidolimab, a high‑affinity humanized immunoglobulin G4
05-27 19:11
美股大行评级 | Arxis、Madison Air获多家大行首予买入评价！潜在涨幅441.87%！Caribou Biosciences获HC Wainwright & Co.升目标价至11美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从9美元升至11美元；康托·菲茨杰拉德：维持Artiva Biotherapeutics"超配"评级，目标价从10美元升至40美元
05-12 12:36
HC Wainwright & Co. Maintains Buy on Vanda Pharmaceuticals, Lowers Price Target to $21
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Vanda Pharmaceuticals (NASDAQ:VNDA) with a Buy and lowers the price target from $24 to $21.
05-11 19:04
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
Vanda Pharmaceuticals' NEREUS Now Commercially Available Throughout U.S. To Prevent Vomiting Induced By Motion In Adults
Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA) today announced that NEREUS™ (tradipitant) is now commercially available across the United States for the prevention of vomiting induced by motion in adults,
05-02 04:38
Vanda Pharmaceuticals Announces Initiation Of The Thetis Study, A Clinical Trial Of NEREUS For The Prevention Of Vomiting Induced By GLP-1 Receptor Agonists; Topline Results From Thetis Study Expected By Q4 2026; Phase 2 Study Succeeded And Met Its Primary Endpoint
Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA) today announced the initiation of Thetis, a clinical trial evaluating NEREUS™ (tradipitant) for the prevention of vomiting in patients receiving glucagon-like
04-09 04:59
Vanda Announces Resignation of Senior Legal Executive
Vanda ( ($VNDA) ) has issued an update. On March 29, 2026, Vanda Pharmaceutical...
04-03 06:04
Vanda Pharmaceuticals Advocates For Stronger FDA Measures To Accelerate Shift From Animal Testing To Human-Relevant Methods
Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA), a leader in innovative drug development and a vocal advocate for reducing unnecessary animal testing, today voiced serious concerns over the U.S. Food and Drug
03-20 04:39
美股夜盘 | Health In Tech, Inc. Class A涨52.94%，ZenaTech, Inc.涨18.42%
Health In Tech, Inc. Class A涨52.94%；ZenaTech, Inc.涨18.42%；万达生物制药涨10.81%
03-18 13:02
美股夜盘 | Health In Tech, Inc. Class A涨50.00%，Energy Vault涨14.29%
Health In Tech, Inc. Class A涨50.00%；Energy Vault涨14.29%；万达生物制药涨10.58%
03-18 10:02
